Qiagen NV | QIA - Equity Capital And Reserves


Qiagen NV reported $3.78B in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
Akebia Therapeutics USD 27.38M 5.24M Mar/2026
Alaunos Therapeutics USD 1.29M 865K Mar/2026
argenx SE USD 7.32B 1.23B Dec/2025
Avita Medical AUD -16.65M 3.76M Dec/2025
Dianthus Therapeutics USD 1.2B 707.91M Mar/2026
Ionis Pharmaceuticals USD 491.41M 2.32M Mar/2026
IQVIA Holdings USD 6.22B 282M Mar/2026
Moderna USD 7.41B 1.24B Mar/2026
Organon & Co USD 903M 151M Mar/2026
Qiagen NV USD 3.78B 128.73M Dec/2025
Revvity USD 7.25B 125.54M Dec/2025
Tectonic Therapeutic USD 230.42M 20.91M Mar/2026
Viatris USD 14.66B 53.6M Mar/2026
Xeris Pharmaceuticals USD 13.01M 678K Mar/2026